Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.

Fifty-five patients with atypical teratoid/rhabdoid tumors of the central nervous system were studied to define the clinical and pathologic features of this newly described neoplasm. The lesion occurred primarily in children younger than 2 (mean age at diagnosis, 17 months). The neoplasms were located in the posterior fossa (36 patients) and the supratentorial compartment (17 patients) or were multifocal in both compartments (2 patients) at presentation. Histologically, the tumors were composed of small cells and large, pale cells in a jumbled architectural arrangement. The small cell component resembled medulloblastoma and occasionally had cords of cells in a mucinous background, simulating chordoma. The cytoplasm of the larger cells was conspicuous with a somewhat "rhabdoid" appearance, although rhabdoid features were not always prominent. Epithelioid features in the form of poorly formed glands or Flexner-Wintersteiner rosettes were noted in a minority of lesions. The neoplasms showed striking polyphenotypic immunoreactivity, including that for vimentin, glial fibrillary acidic protein, epithelial membrane antigen, cytokeratins, synaptophysin, chromogranin, and smooth muscle actin. Using a probe for chromosome 22, seven of eight scorable cases showed a solitary signal by fluorescence in situ hybridization (FISH) consistent with monosomy 22. The eighth scorable case showed three signals by fluorescence in situ hybridization and had a translocation involving chromosome 22 reported by conventional cytogenetics. In contrast to patients with medulloblastoma, the neoplasm with which these lesions are often confused, the outcome of the patients was uniformly poor. The mean postoperative survival of patients with atypical teratoid/rhabdoid tumors was only 11 months. Local recurrence, seeding of the cerebrospinal fluid pathways, or both, were common terminal events. This study underscores the distinctive clinical, histopathologic, immunohistochemical, and cytogenetic character of this unusually aggressive tumor.

[1]  I W Taylor,et al.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  J. Bonnin,et al.  The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases , 1984, Cancer.

[3]  M. Gonzales,et al.  Primitive neuroectodermal tumour of the central nervous system associated with malignant rhabdoid tumour of the kidney: report of a case , 1986, Histopathology.

[4]  J. Powers,et al.  Malignant rhabdoid tumor of the central nervous system. , 1987 .

[5]  W. Sakr,et al.  Primitive neuroectodermal tumor of the brain associated with malignant rhabdoid tumor of the liver: a histologic, immunohistochemical, and electron microscopic study. , 1989, Pediatric pathology.

[6]  T. Chou,et al.  Primary malignant rhabdoid tumor of the brain: CT characteristics. , 1990, Journal of computer assisted tomography.

[7]  P. Houghton,et al.  Malignant rhabdoid tumor: A highly malignant childhood tumor with minimal karyotypic changes , 1990, Genes, chromosomes & cancer.

[8]  J. Biegel,et al.  Monosomy 22 in rhabdoid or atypical tumors of the brain. , 1990, Journal of neurosurgery.

[9]  A. Js,et al.  Primary CNS malignant rhabdoid tumor (MRT): report of two cases and review of literature. , 1991 .

[10]  D. Gusnard,et al.  Rhabdoid tumor of the central nervous system. , 1991, Medical and pediatric oncology.

[11]  H. Shimada,et al.  Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46,XY,t(11;22)(p15.5;q11.23). , 1991, Cancer genetics and cytogenetics.

[12]  M. Cohen,et al.  Changes in the approach to central nervous system tumors in childhood. , 1992, Pediatric clinics of North America.

[13]  L. Ang,et al.  Malignant rhabdoid tumor of the central nervous system with subarachnoid dissemination. , 1992, Surgical neurology.

[14]  M. Loda,et al.  Large‐Cell Medulloblastomas: A Distinct Variant with Highly Aggressive Behavior , 1992, The American journal of surgical pathology.

[15]  J. Biegel,et al.  Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor , 1992, Genes, chromosomes & cancer.

[16]  T. Triche,et al.  Malignant rhabdoid tumor. A study with two established cell lines , 1993, Cancer.

[17]  J. Langston,et al.  Primary malignant rhabdoid tumor of the brain: clinical, imaging, and pathologic findings. , 1993, AJNR. American journal of neuroradiology.

[18]  D. Parham,et al.  The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. , 1994, The American journal of surgical pathology.

[19]  F. Askin,et al.  Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. , 1994, Human pathology.

[20]  W. Cavenee,et al.  The t(II; 22)(pI5.5; qII.23) in a retroperitoneal rhabdoid tumor also includes a regional deletion distal to CRYBB2 on 22q , 1995 .

[21]  P. Dirks,et al.  Characterization of a pineal region malignant rhabdoid tumor. Towards understanding brain tumor cell invasion. , 1995, Pediatric neurosurgery.

[22]  T. Olson,et al.  Successful Treatment of Disseminated Central Nervous System Malignant Rhabdoid Tumor , 1995, Journal of pediatric hematology/oncology.

[23]  L. Rorke,et al.  Primary intracranial atypical teratoid/rhabdoid tumor in a child with Canavan disease. , 1995, Pediatric neurosurgery.

[24]  J. Biegel,et al.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. , 1996, Journal of neurosurgery.